Clinical Context
A hospitalized adult with severe COVID-19 pneumonia receiving systemic corticosteroids and requiring supplemental oxygen or ventilatory support is evaluated for adjunctive immunomodulatory therapy. The patient has hypoxemia on supplemental oxygen via nasal cannula or high-flow device, or is receiving non-invasive ventilation, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). After infectious disease and critical care teams confirm indications and review contraindications (active uncontrolled infection, elevated transaminases beyond recommended thresholds, or severe neutropenia/thrombocytopenia), an order for intravenous tocilizumab is placed for a single dose with the potential for a second dose per institutional protocol. The clinical workflow includes: medication order entry and allergy verification; baseline labs (CBC, CMP, liver enzymes, coagulation studies); pharmacy preparation and verification of tocilizumab-aazg dose; infusion in an inpatient infusion suite, ICU, or step-down unit with continuous monitoring (vital signs, oxygenation) during infusion; documentation of infusion start and stop times, lot number, and administration site; post-administration monitoring for infusion reactions and delayed adverse events; and reassessment for clinical response and need for a second dose. Billing captures the infused biologic, administration, and post-administration monitoring under the HCPCS Level II code M0234 representing the second dose of intravenous tocilizumab-aazg for hospitalized adult COVID-19 patients meeting the specified clinical criteria.
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|
36415 | Collection of venous blood by venipuncture | Performed prior to M0234 for baseline labs (CBC, CMP, liver enzymes) |
96365 | Intravenous infusion, initial, up to 1 hour | Used for billing IV infusion services when institutional billing requires a CPT code for infusion time that accompanies biologic administration — document infusion start/stop times
96366 | Intravenous infusion, each additional hour | Used if the infusion extends beyond the initial hour and facility/payer policy requires additional infusion time reporting
93000 | Electrocardiogram, routine ECG with interpretation and report | Performed in patients with cardiopulmonary instability prior to or during treatment as clinically indicated
99291 | Critical care, evaluation and management of the critically ill or critically injured, first 30–74 minutes | Used when critical care time is rendered on the same day as M0234 and meets critical care documentation standards
99406 | Smoking and tobacco-use cessation counseling intermediate, greater than 3 minutes up to 10 minutes | Ancillary counseling that may occur during hospitalization (included here as an example of common inpatient counseling services)
Note: If payer policy requires only HCPCS billing for the biologic and its administration, facility billing will reference M0234; associated CPT codes above are commonly performed alongside or as part of the inpatient clinical workflow.